Depression Severity Moderates Reward Learning Among Smokers With Current or Past Major Depressive Disorder in a Smoking Cessation Randomized Clinical Trial

Author:

Gollan Jacqueline K1ORCID,Liverant Gabrielle2,Jao Nancy C3,Lord Kayla A4,Whitton Alexis E5ORCID,Hogarth Lee6ORCID,Fox Erica7,Bauer Anna-Marika8,Quinn Mackenzie Hosie8,Pizzagalli Diego A9ORCID,Leone Frank T10,Papandonatos George D11,Schnoll Robert A811,Hitsman Brian17ORCID

Affiliation:

1. Department of Psychiatry and Behavioral Sciences, Northwestern University , Chicago, IL , USA

2. Department of Psychology, Suffolk University , Boston, MA , USA

3. Rosalind Franklin University of Medicine and Science , North Chicago, IL , USA

4. Institute of Living, Hartford Hospital , Hartford, CT , USA

5. Black Dog Institute, The University of New South Wales , Sydney, New South Wales , Australia

6. Department of Psychology, University of Exeter , Exeter , UK

7. Department of Preventive Medicine, Feinberg School of Medicine, Northwestern University , Chicago, IL , USA

8. Department of Psychiatry, Perelman School of Medicine, University of Pennsylvania , Philadelphia, PA , USA

9. Department of Psychiatry, Harvard Medical School , Boston, MA , USA

10. Pulmonary, Allergy & Critical Care Division, Perelman School of Medicine, University of Pennsylvania , Philadelphia, PA , USA

11. Center for Statistical Sciences, Brown University , Providence, RI , USA

Abstract

Abstract Introduction Behavioral and pharmacological smoking cessation treatments are hypothesized to increase patients’ reward learning to reduce craving. Identifying changes in reward learning processes that support effective tobacco-dependence interventions among smokers who experience depression may guide patients toward efficient treatment strategies. The objective was to investigate the extent to which adult daily cigarette smokers with current or past major depressive disorder (MDD) learned to seek reward during 12 weeks of treatment combining behavioral activation and varenicline. We hypothesized that a decline in reward learning would be attenuated (least to most) in the following order: (1) behavioral activation integrated with ST (BASC) + varenicline, (2) BASC + placebo, (3) standard behavioral cessation treatment (ST) + varenicline, (4) ST + placebo. Methods We ran a phase IV, placebo-controlled, randomized clinical trial with 300 participants receiving 12 weeks of one of four conditions across two urban medical centers. Depressive symptoms were measured using the Beck Depression Inventory-II (BDI). Reward learning was ascertained at weeks 1, 7, and 14 using the Probabilistic Reward Task (PRT), a laboratory task that uses an asymmetric reinforcement schedule to assess (a) learning to seek reward (response bias), (b) differentiate between stimuli, and (c) time to react to cues. Results There was a significant interaction of BDI group × PRT response bias. Response bias declined from weeks 7 to 14 among participants with high baseline depression symptoms. The other two BDI groups showed no change in response bias. Conclusions Controlling for baseline depression, participants showed a decrease in response bias from weeks 1 to 14, and from weeks 7 to 14. Treatment condition and abstinence status were unassociated with change in reward learning. Implications Smokers who report greater depression severity show a decline in reward learning despite their participation in smoking cessation treatments, suggesting that depressed populations pose unique challenges with standard smoking cessation approaches. Trial Registration ClinicalTrials.gov Identifier: NCT02378714.

Funder

National Cancer Institute

Department of Preventive Medicine, Northwestern University Feinberg School of Medicine

Robert H. Lurie Comprehensive Cancer Center of Northwestern University

National Institutes of Health

National Center for Advancing Translational Sciences

Publisher

Oxford University Press (OUP)

Subject

Public Health, Environmental and Occupational Health

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3